Sagility Limited — Call Transcript 2025

Jan 31, 2025

==> picture [134 x 32] intentionally omitted <==

Date: January 31, 2025

To,

The Manager Listing Department National Stock Exchange (NSE) Exchange Plaza, 5th Floor Plot No. C/1, G-Block Bandra-Kurla Complex Bandra (E), Mumbai - 400 051 Symbol: SAGILITY

The Manager Listing Department Bombay Stock Exchange (BSE) Phiroze Jeejeebhoy Towers Dalal Street Mumbai - 400 001 Scrip Code:544282

Dear Sir/Ma’am,

Subject: Revised intimation of investors call pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

This is further to our communication dated January 30, 2025, regarding the intimation of investor/analyst webinar for discussing the unaudited financial results of the Company for the quarter ended 31[st] December 2024 to be held on Wednesday, 05[th] February 2025, please note that webinar is re-scheduled to 7:00 P.M. The details of the call are provided as an annexure to this letter.

The details are also being made available on the Company’s website www.sagilityhealth.com

This is for your kind information and record

Thanking You,

For Sagility India Limited

SATISHKUMAR Digitally signed by SATISHKUMAR SAKHARAYAPATTAN SAKHARAYAPATTANA SEETHARAMAIAH A SEETHARAMAIAH Date: 2025.01.31 18:25:09 +05'30'

Satishkumar Sakharayapattana Seetharamaiah

Company Secretary & Compliance Officer Membership No: A16008

Encl:a/a

Sagility India Limited

(Formerly Sagility India Private Limited)

Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru – 560068, Karnataka, India

Corporate Identity Number: U72900KA2021PLC150054

Tel. No.: 080-71251500, Website: www.SagilityHealth.com

Sagility India Ltd.

Q3 & 9M FY25 Earnings Webinar Rescheduled to 07:00 PM IST on Wednesday, February 05, 2025

Bengaluru, January 31, 2025 — Sagility India Limited (SAGILITY), a technology-enabled, pure-play healthcare focused solutions and services provider, will host its earnings webinar for analysts and investors on Wednesday, February 05, 2025, at 07:00 PM IST. The call will commence with a discussion on the business, followed by operational and financial highlights for the quarter and nine months ending December 31, 2024. There is an interactive Question & Answer session planned after the presentation.

The Company will be represented by

• Mr. Ramesh Gopalan – Managing Director and Group CEO

• • Mr. Sarvabhouman Srinivasan – Group Chief Financial Officer

Dial-in details are as follows:

Timing 07:00 PM IST on Wednesday, February 05, 2025 – Pre-registration Link Sagility Q3 & 9M FY25 Concall Registration Link

• Platform : Zoom. Please download the latest app for your device: Download Link.

• Pre-Registration : Mandatory. Register up to 3 hours before the call using the provided link.

• Q&A Session : After management's commentary, participants may join the queue by clicking the “Raise Hand” icon during the commentary. When announced, unmute yourself using the “Unmute Me” button to ask your question.

About Sagility India Limited.

Sagility is a technology-enabled, healthcare-focused solutions and services provider that supports U.S.-based payers, providers, and their partners in delivering best-in-class operations, enhancing member and provider experiences, and improving the quality of care, all while ensuring cost-effective financial and clinical outcomes.

With over two decades of experience, Sagility’s dedicated experts address complex healthcare challenges through deep domain expertise and innovative thinking. The company serves five of the top ten health insurance companies in the U.S., utilizing its advanced technology, processes, and solutions to ensure efficient operations and minimize additional administrative costs. The Company delivers these services through its skilled talent pool across five global service delivery centers located in India, the Philippines, the U.S., Jamaica, and Colombia.

For more information, please visit www.sagilityhealth.com OR contact: Mr. Abhishek Kayan Siddharth Rangnekar Sagility India Limited CDR India Email: investorservices@sagilityhealth.com Email: siddharth@cdr-india.com

Safe Harbor:

Certain statements made in this call concerning our future growth prospects may be interpreted as forward-looking statements, which involve a number of risks and uncertainties that could cause the actual results to differ materially from those in such forward-looking statements. Investors are requested to use their discretion in relying on them. We do not undertake to update any forward-looking statements that may be made from time to time.